Abstract
Jamie Dean, Kee Wong, Hiram Gay, Liam Welsh, Ann-Britt Jones, Ulricke Schick, Jung Hun Oh, Aditya Apte, Kate Newbold, Shreerang Bhide, Kevin Harrington, Joseph Deasy, Christopher Nutting, Sarah Gulliford
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical predictors of quality of life in patients with head and neck cancer
10.1001/archotol.130.4.401 · 2004
The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity
10.1002/(sici)1097-0142(19960601)77:11<2294::aid-cncr17>3.0.co;2-s · 1996
Combined chemotherapy and radiation therapy for head and neck malignancies
10.1002/cncr.10257 · 2002
Mucositis: the impact, biology and therapeutic opportunities of oral mucositis
10.1016/j.oraloncology.2009.08.006 · 2009
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
10.1038/nrc1950 · 2006
Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia
10.1016/j.radonc.2015.01.019 · 2015
Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients
10.1016/j.radonc.2010.09.028 · 2010
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach
10.1016/j.radonc.2013.05.007 · 2013
Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer
10.1200/jco.2009.24.7221 · 2010
Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study
10.1016/j.radonc.2011.08.009 · 2012
Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer
10.1016/j.radonc.2014.09.013 · 2014
Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach
10.1016/j.radonc.2015.11.009 · 2016
Development and validation of a prediction model for tube feeding dependence after curative (Chemo-) radiation in head and neck cancer
10.1371/journal.pone.0094879 · 2014
Toward a model-based patient selection strategy for proton therapy: external validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort
10.1016/j.radonc.2016.08.022 · 2016
Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes
10.1016/j.ijrobp.2008.08.073 · 2009
A predictive model for dysphagia following IMRT for head and neck cancer: introduction of the EMLasso technique
10.1016/j.radonc.2013.03.021 · 2013
Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer
10.1016/j.ijrobp.2009.10.057 · 2011
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer
10.3109/0284186x.2013.824609 · 2013
Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients
10.1038/s41598-017-07586-x · 2017
Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients
10.1016/j.radonc.2016.05.017 · 2016
Radiation-induced acute dysphagia. Prospective observational study on 42 head and neck cancer patients
10.1007/s00066-017-1206-x · 2017
Organ-sparing radiation therapy for head and neck cancer
10.1038/nrclinonc.2011.106 · 2011
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus
10.1016/j.critrevonc.2015.06.005 · 2015
Function, muscles, and sparing by IMRT for head-and-neck cancer
10.1016/j.ijrobp.2012.08.040 · 2013
Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial
10.1016/j.radonc.2012.02.006 · 2012
The dose-response of the anal sphincter region – An analysis of data from the MRC RT01 trial
10.1016/j.radonc.2012.03.002 · 2012
Evaluation of the risk of grade 3 oral and pharyngeal dysphagia using atlas-based method and multivariate analyses of individual patient dose distributions
10.1016/j.ijrobp.2015.07.2263 · 2015
Functional data analysis applied to modeling of severe acute mucositis and dysphagia resulting from head and neck radiation therapy
10.1016/j.ijrobp.2016.08.013 · 2016
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
10.1016/s1470-2045(10)70290-4 · 2011
Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers
10.1016/j.oraloncology.2014.07.018 · 2014
A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes
10.1038/bjc.2014.553 · 2015
Induction chemotherapy followed by chemo-intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer
10.1016/j.clon.2016.01.012 · 2016
Total mucosal irradiation with intensity-modulated radiotherapy in patients with head and neck carcinoma of unknown primary: a pooled analysis of two prospective studies
10.1016/j.clon.2016.04.035 · 2016
Unresolved referenced work
Kept as external metadata until matched
Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94–06
10.1016/j.radonc.2012.04.023 · 2012
Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy
10.1016/j.radonc.2016.05.015 · 2016
Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods
1999
Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework
10.1053/j.seminoncol.2009.12.004 · 2010
Bias in random forest variable importance measures: illustrations, sources and a solution
10.1186/1471-2105-8-25 · 2007
A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer
10.1016/j.radonc.2008.12.017 · 2009
Decision curve analysis: a novel method for evaluating prediction models
10.1177/0272989x06295361 · doi-reference
Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans
10.1016/j.radonc.2014.08.020 · doi-reference
Does PEG use cause dysphagia in head and neck cancer patients?
10.1007/s00455-011-9360-2 · doi-reference
Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer
10.1016/j.ijrobp.2009.09.036 · doi-reference
A calibration hierarchy for risk models was defined: from utopia to empirical data
10.1016/j.jclinepi.2015.12.005 · doi-reference
10.25080/majora-92bf1922-00a
10.25080/majora-92bf1922-00a · doi-reference
Transparent reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): explanation and elaboration
10.7326/m14-0698 · doi-reference
Validation and updating of predictive logistic regression models: a study on sample size and shrinkage
10.1002/sim.1844 · doi-reference
How to develop a more accurate risk prediction model when there are few events
10.1136/bmj.h3868 · doi-reference
Assessing the performance of prediction models: a framework for traditional and novel measures
10.1097/ede.0b013e3181c30fb2 · doi-reference
Verification of forecasts expersses in terms of probaility
10.1175/1520-0493(1950)078<0001:vofeit>2.0.co;2 · doi-reference
Rational decisions
10.1111/j.2517-6161.1952.tb00104.x · doi-reference
Random Forests
10.1023/a:1010933404324 · doi-reference
Support-Vector Networks
10.1007/bf00994018 · doi-reference
Regression shrinkage and selection via the Lasso
10.1111/j.2517-6161.1996.tb02080.x · doi-reference
SU-E-T-33: Pydicom: an open source DICOM library
10.1118/1.3611983 · doi-reference
Matplotlib: a 2D graphics environment
10.1109/mcse.2007.55 · doi-reference
The NumPy array: a structure for efficient numerical computation
10.1109/mcse.2011.37 · doi-reference
Using dose-surface maps to predict radiation-induced rectal bleeding: a neural network approach
10.1088/0031-9155/54/17/005 · doi-reference
Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer
10.1118/1.2907707 · doi-reference
Radiation dose-volume effects in the esophagus
10.1016/j.ijrobp.2009.05.070 · doi-reference
Small data sets to develop and validate prognostic models are problematic
10.1016/j.ejca.2015.09.025 · doi-reference
Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes
10.1016/j.ijrobp.2012.08.030 · doi-reference
Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer
10.1016/j.ijrobp.2009.05.049 · doi-reference
Dose-volume response in acute dysphagia toxicity: validating QUANTEC recommendations into clinical practice for head and neck radiotherapy
10.3109/0284186x.2014.933874 · doi-reference
Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction
10.1016/j.radonc.2013.05.004 · doi-reference